Hochschulschrift
Characterization of two antigens that bind an anti-anti-KDEL network antibody
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
III, 181 Bl.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Heidelberg, Univ., Diss., 1994
- Urheber
-
Hendriks, Robertus Johannes Maria
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Hendriks, Robertus Johannes Maria
Ähnliche Objekte (12)
Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
“Redirecting an anti-IL-1β antibody to bind a new, unrelated and computationally predicted epitope on hIL-17A”
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity
An anti vimentin antibody promotes tube formation
Antigen antibody interactions
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates
Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures
Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
“Redirecting an anti-IL-1β antibody to bind a new, unrelated and computationally predicted epitope on hIL-17A”
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity
An anti vimentin antibody promotes tube formation
Antigen antibody interactions
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates
Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures
Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
“Redirecting an anti-IL-1β antibody to bind a new, unrelated and computationally predicted epitope on hIL-17A”
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
Developing anti-tumor vaccines : antigens and antigen-presenting cells
Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody
An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity
An anti vimentin antibody promotes tube formation
Antigen antibody interactions
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates
Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis